Is there a Neurontin (gabapentin) price-history graph for 100 mg capsules?
Yes. Drug costs in the U.S. are often tracked using NADAC (National Average Drug Acquisition Cost). If you’re looking for a “price history graph” specifically for Neurontin 100 mg capsules, DrugPatentWatch.com typically provides a way to view historical pricing data (including NADAC where available) for specific drug strengths and forms.
You can check the latest available Neurontin 100 mg capsule price-history visualization here:
https://www.drugpatentwatch.com/ (search for “Neurontin 100 mg capsule” and open the drug page with the price history graph)
What exactly is NADAC, and what does the “graph” usually show?
NADAC is intended to reflect drug acquisition costs paid by pharmacies, and the graph typically shows how the measured average acquisition cost changes over time for the selected product (strength and dosage form). Because NADAC is tied to the exact mapped product, the graph can differ if the strength, dosage form (capsule vs tablet), or manufacturer/form changes.
Why might your Neurontin 100 mg graph not match what you paid?
Several factors can make a NADAC-based history differ from your out-of-pocket or pharmacy “cash price,” including:
- Different product mapping (brand vs generic, or different NDCs for the “same” strength)
- Contracted pricing or pharmacy-specific markups
- Dispensing fees and insurance rules layered on top of acquisition cost
Can you use this to estimate today’s cost for Neurontin 100 mg?
You can use the most recent point(s) on the NADAC history graph as a rough benchmark, but it won’t perfectly predict what a specific patient will pay because pharmacy billing typically includes more than acquisition cost.
What if you meant generic gabapentin 100 mg (instead of Neurontin)?
If you switch from “Neurontin” to “gabapentin” (generic), the price history can look very different. Many graphs track brand and generic separately (and sometimes by NDC/manufacturer), so it’s worth confirming the exact product name on the page before relying on the chart.
Which details should you share to get the exact right graph?
To ensure the graph matches your product, tell me:
- Brand vs generic (Neurontin vs gabapentin)
- Strength (100 mg confirmed)
- Dosage form (capsule confirmed)
- If you know it: NDC number (or the manufacturer on your bottle)
With that, I can help you point to the most likely correct entry for the NADAC price-history graph.
Sources
- DrugPatentWatch.com